It’s hard to imagine a startup better positioned to respond to the coronavirus pandemic than Beverly, Massachusetts-based LexaGene. The company is developing a fully automated genetic analyzer to identify pathogens, bacteria and viruses like the coronavirus, designed to be used at the site of sample collection and return results in about one hour.....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.